{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=placebo+ointment&page=2", "query": { "intervention": "placebo ointment", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=placebo+ointment&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-28T06:06:05.759Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03394677", "title": "Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "RVT-501 0.5% ointment", "type": "DRUG" }, { "name": "Vehicle ointment", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dermavant Sciences GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Years to 17 Years" }, "enrollment_count": 110, "start_date": "2018-01-25", "completion_date": "2018-07-02", "has_results": false, "last_update_posted_date": "2018-07-19", "last_synced_at": "2026-09-28T06:06:05.759Z", "location_count": 5, "location_summary": "Los Angeles, California • Oklahoma City, Oklahoma • Portland, Oregon + 2 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "Portland", "state": "Oregon" }, { "city": "Dallas", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03394677" }, { "nct_id": "NCT01597050", "title": "Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lupus Erythematosus, Discoid", "Lupus Erythematosus, Systemic" ], "interventions": [ { "name": "R932333", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rigel Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 54, "start_date": "2012-08", "completion_date": "2013-09", "has_results": true, "last_update_posted_date": "2016-07-14", "last_synced_at": "2026-09-28T06:06:05.759Z", "location_count": 12, "location_summary": "Los Angeles, California • Redwood City, California • South Bend, Indiana + 9 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Redwood City", "state": "California" }, { "city": "South Bend", "state": "Indiana" }, { "city": "Lake Success", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01597050" }, { "nct_id": "NCT02607683", "title": "Phase 2b/3 Study of XAF5 Ointment for Steatoblepharon (Undereye Bags)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Steatoblepharon" ], "interventions": [ { "name": "XAF5 (concentration A: 0.1%)", "type": "DRUG" }, { "name": "XAF5 (concentration B: 0.035%)", "type": "DRUG" }, { "name": "Matching placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Topokine Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "40 Years to 70 Years" }, "enrollment_count": 300, "start_date": "2016-01-01", "completion_date": "2016-10-31", "has_results": false, "last_update_posted_date": "2017-11-08", "last_synced_at": "2026-09-28T06:06:05.759Z", "location_count": 6, "location_summary": "Newport Beach, California • Santa Ana, California • Danbury, Connecticut + 3 more", "locations": [ { "city": "Newport Beach", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Danbury", "state": "Connecticut" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Wantagh", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02607683" }, { "nct_id": "NCT00625326", "title": "Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Plaque-type Psoriasis" ], "interventions": [ { "name": "COL-121", "type": "DRUG" }, { "name": "50 µg/g Calcipotriene Ointment", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Deltanoid Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 321, "start_date": "2008-01", "completion_date": "2009-06", "has_results": false, "last_update_posted_date": "2011-04-27", "last_synced_at": "2026-09-28T06:06:05.759Z", "location_count": 20, "location_summary": "Fremont, California • Los Angeles, California • San Diego, California + 17 more", "locations": [ { "city": "Fremont", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Vista", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00625326" }, { "nct_id": "NCT05608343", "title": "This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Difamilast", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Acrotech Biopharma Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 153, "start_date": "2022-10-01", "completion_date": "2023-10-27", "has_results": false, "last_update_posted_date": "2024-08-15", "last_synced_at": "2026-09-28T06:06:05.759Z", "location_count": 39, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Jonesboro, Arkansas + 36 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Fremont", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05608343" }, { "nct_id": "NCT01831804", "title": "Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Wound Healing" ], "interventions": [ { "name": "GSK1278863", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 65, "start_date": "2013-06-17", "completion_date": "2017-02-10", "has_results": true, "last_update_posted_date": "2019-08-19", "last_synced_at": "2026-09-28T06:06:05.759Z", "location_count": 7, "location_summary": "Castro Valley, California • Washington D.C., District of Columbia • Miami, Florida + 4 more", "locations": [ { "city": "Castro Valley", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Miami", "state": "Florida" }, { "city": "Pinellas Park", "state": "Florida" }, { "city": "Las Vegas", "state": "Nevada" } ], "official_url": "https://clinicaltrials.gov/study/NCT01831804" }, { "nct_id": "NCT00932074", "title": "A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "KP-413 Ointment", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kaken Pharmaceutical", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 58, "start_date": "2009-07", "completion_date": "2010-06", "has_results": false, "last_update_posted_date": "2012-04-06", "last_synced_at": "2026-09-28T06:06:05.759Z", "location_count": 6, "location_summary": "Clinton Twp., Michigan • Portland, Oregon • Austin, Texas + 3 more", "locations": [ { "city": "Clinton Twp.", "state": "Michigan" }, { "city": "Portland", "state": "Oregon" }, { "city": "Austin", "state": "Texas" }, { "city": "College Station", "state": "Texas" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00932074" }, { "nct_id": "NCT05525468", "title": "A Phase 1 Study of TDM-180935 Following Topical Administration in Healthy Male Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "TDM-180935", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Technoderma Medicines Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 58, "start_date": "2023-02-08", "completion_date": "2023-10-13", "has_results": false, "last_update_posted_date": "2023-11-18", "last_synced_at": "2026-09-28T06:06:05.759Z", "location_count": 1, "location_summary": "Fair Lawn, New Jersey", "locations": [ { "city": "Fair Lawn", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05525468" }, { "nct_id": "NCT02601703", "title": "To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Tacrolimus Ointment 0.1%", "type": "DRUG" }, { "name": "Protopic® ointment, 0.1%", "type": "DRUG" }, { "name": "Placebo of Tacrolimus Ointment", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Glenmark Pharmaceuticals Ltd. India", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1110, "start_date": "2015-08", "completion_date": "2016-10", "has_results": false, "last_update_posted_date": "2019-07-31", "last_synced_at": "2026-09-28T06:06:05.759Z", "location_count": 60, "location_summary": "Tempe, Arizona • Anaheim, California • Bell Gardens, California + 43 more", "locations": [ { "city": "Tempe", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Bell Gardens", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Chula Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02601703" }, { "nct_id": "NCT03285490", "title": "A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Actinic Keratosis" ], "interventions": [ { "name": "KX2-391 Ointment 1%", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Almirall, S.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 351, "start_date": "2017-09-15", "completion_date": "2019-04-24", "has_results": true, "last_update_posted_date": "2021-03-10", "last_synced_at": "2026-09-28T06:06:05.759Z", "location_count": 30, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Hot Springs, Arkansas + 27 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Murrieta", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03285490" } ] }